(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

EPYZTEK

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

EPYZTEK

ST13

US500000079367091

Class

5

Filing

79367091

Registration

7185317

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

13

Latest update

12/02/2023

Trademark type

Word

Nice classes

5

Filing date

02/28/2023

Registration date

10/10/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/10/2023

Last transaction

10/10/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

03

Owner location

KR

Examiner

BARRETT, LEAH

Law office

N80

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

SAMSUNG BIOEPIS CO., LTD.

Representatives

KAI International IP Law Firm

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for the treatment of hematologicalautoimmuneinflammatoryrespiratorytransplantation-related diseases and disorders; pharmaceutical preparations for the treatment of generalized myasthenia gravis; pharmaceutical preparations for use in hematology; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical preparations for the treatment of inflammatory diseases; pharmaceutical preparations for treating respiratory diseases; pharmaceutical preparations for the treatment of ulcerative colitis; antidiabetic preparations; human vaccine preparations; pharmaceutical preparationspharmaceutical preparationsbiological formulationsbiological preparationsantibody formulations and protein formulations for immunoregulation and for treatment of immunologic disordersautoimmune diseasesinflammatory diseasesarthritiscancertumorcentral nervous system disorders and metabolic diseases; anti-inflammatory preparations; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for tumor treatment; pharmaceutical preparations for the treatment of diseases of the metabolic system; pharmaceutical preparations for skin treatment; pharmaceutical preparations for psoriasis treatment; pharmaceutical preparations for the treatment of psoriatic arthritis; pharmaceutical preparations for the treatment of Crohn's disease; dietary supplements

Publications

History of USPTO decisions and trademark events.

13 publications found

GPNX

NOTIFICATION PROCESSED BY IB

12/02/2023

FICS

FINAL DISPOSITION NOTICE SENT TO IB

11/13/2023

FIMP

FINAL DISPOSITION PROCESSED

11/13/2023

GPAR

GRANT OF PROTECTION CREATED, TO BE SENT TO IB

11/09/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

10/10/2023

PUBO

PUBLISHED FOR OPPOSITION

07/25/2023

NPUB

NOTICE OF PUBLICATION

07/05/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/22/2023

DOCK

ASSIGNED TO EXAMINER

06/22/2023

MAFR

APPLICATION FILING RECEIPT MAILED

05/13/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/09/2023

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

04/24/2023

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

04/07/2023

Continuous trademark protection

Get notified about every new filing that threatens EPYZTEK or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.